As of January 22, 2025, Solid Biosciences (SLDB) has a market cap of $0.12 billion USD. According to our data, Solid Biosciences is ranked No.7521 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.12 B |
-22.00%
|
Dec 31, 2024 | $0.16 B |
-34.85%
|
Dec 29, 2023 | $0.25 B |
14.13%
|
Dec 30, 2022 | $0.21 B |
-79.50%
|
Dec 31, 2021 | $1.05 B |
-76.91%
|
Dec 31, 2020 | $4.54 B |
70.34%
|
Dec 31, 2019 | $2.67 B |
-83.40%
|
Dec 31, 2018 | $16.06 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
REGENXBIO
RGNX
|
$0.39 B |
-0.000 M
|
USA
|
Boundless Bio
BOLD
|
$57.31 M |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Ultragenyx
RARE
|
$3.97 B |
0.000 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Rocket Pharmaceuticals
RCKT
|
$1.11 B |
-0.000 M
|
USA
|
Precision BioSciences
DTIL
|
$38.13 M |
0.000 M
|
USA
|
Voyager Therapeutics
VYGR
|
$0.30 B |
-0.000 M
|
USA
|
Market Cap | = | SLDB Stock Price | * | SLDB Shares Outstanding |
= | $3.12 | * | 39.95 M | |
= | $0.12 B |